Fibrous Dysplasia clinical trials

Explore recruiting fibrous dysplasia clinical trials.

Recruiting fibrous dysplasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fibrous Dysplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): a randomized double-blind placebo-controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Fibrous Dysplasia trials by city

Fibrous Dysplasia in Toronto Fibrous Dysplasia in Vancouver Fibrous Dysplasia in Montreal Fibrous Dysplasia in Calgary Fibrous Dysplasia in Edmonton Fibrous Dysplasia in Ottawa Fibrous Dysplasia in Winnipeg Fibrous Dysplasia in Quebec City Fibrous Dysplasia in Hamilton Fibrous Dysplasia in Kitchener Fibrous Dysplasia in London Fibrous Dysplasia in Halifax Fibrous Dysplasia in New York Fibrous Dysplasia in Los Angeles Fibrous Dysplasia in Chicago Fibrous Dysplasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease